These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 34250823)
1. Correlation of 18F-FDG PET/CT SUVmax with clinical features, D-dimer and LDH in patients with primary intestinal lymphoma. Zhou S; Chen W; Lin M; Chen G; Chen C; Huo C; Du X J Int Med Res; 2021 Jul; 49(7):3000605211029809. PubMed ID: 34250823 [TBL] [Abstract][Full Text] [Related]
2. [ Guan W; Wang QS; Wu HB; Zhou WL Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1175-1180. PubMed ID: 27687646 [TBL] [Abstract][Full Text] [Related]
3. Correlations between maximum standardized uptake value measured via Li H; Wang X; Zhang L; Yi X; Qiao Y; Jin Q J Cancer Res Ther; 2019; 15(7):1581-1588. PubMed ID: 31939441 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT in primary brain lymphoma. Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement. Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience. Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357 [TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in splenic marginal zone lymphoma. Albano D; Giubbini R; Bertagna F Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652 [TBL] [Abstract][Full Text] [Related]
9. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
10. Multiple metabolic parameters and visual assessment of Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551 [TBL] [Abstract][Full Text] [Related]
11. [Correlation and Influencing Factors of SUVmax and Ki-67 in Non-Hodgkin Lymphoma]. Li J; Zhao M; Yuan L; Liu Y; Ma N Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):136-140. PubMed ID: 35123616 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features. Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma. Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature. Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024 [TBL] [Abstract][Full Text] [Related]
15. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma. Karunanithi S; Sharma P; Roy SG; Vettiyil B; Sharma A; Thulkar S; Bal C; Kumar R Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015 [TBL] [Abstract][Full Text] [Related]
16. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma. Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465 [TBL] [Abstract][Full Text] [Related]
18. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma. Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma. Ahmadzadehfar H; Rodrigues M; Zakavi R; Knoll P; Mirzaei S Med Oncol; 2011 Dec; 28(4):1570-6. PubMed ID: 20524086 [TBL] [Abstract][Full Text] [Related]
20. Correlation of [18F]FDG PET activity with expressions of Ki-67 in non-small-cell lung cancer. Kucukosmanoglu I; Karanis MIE; Unlu Y; Erol M Nucl Med Rev Cent East Eur; 2022; 25(2):73-77. PubMed ID: 36047292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]